Active, not recruitingNot applicableNCT02950987

Screening With Whole Body MRI For Detection Of Primary Tumors In Children And Adults With Li-Fraumeni Syndrome (LFS) And Other Cancer Predisposition Syndromes

Studying Li-Fraumeni syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Dana-Farber Cancer Institute
Principal Investigator
Allison O'Neill, MD
Dana-Farber Cancer Institute
Intervention
Whole Body MRI(device)
Enrollment
150 enrolled
Eligibility
All sexes
Timeline
2012 – 2027

Study locations (3)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02950987 on ClinicalTrials.gov

Other trials for Li-Fraumeni syndrome

Additional recruiting or active studies for the same condition.

See all trials for Li-Fraumeni syndrome →

← Back to all trials